365 related articles for article (PubMed ID: 34108970)
1. Macrophage Function in Calcium Oxalate Kidney Stone Formation: A Systematic Review of Literature.
Taguchi K; Okada A; Unno R; Hamamoto S; Yasui T
Front Immunol; 2021; 12():673690. PubMed ID: 34108970
[TBL] [Abstract][Full Text] [Related]
2. Sulforaphane elicts dual therapeutic effects on Renal Inflammatory Injury and crystal deposition in Calcium Oxalate Nephrocalcinosis.
Liu H; Yang X; Tang K; Ye T; Duan C; Lv P; Yan L; Wu X; Chen Z; Liu J; Deng Y; Zeng G; Xing J; Ye Z; Xu H
Theranostics; 2020; 10(16):7319-7334. PubMed ID: 32641994
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy for stone disease.
Dominguez-Gutierrez PR; Kwenda EP; Khan SR; Canales BK
Curr Opin Urol; 2020 Mar; 30(2):183-189. PubMed ID: 31913203
[TBL] [Abstract][Full Text] [Related]
4. Loss of the androgen receptor suppresses intrarenal calcium oxalate crystals deposition via altering macrophage recruitment/M2 polarization with change of the miR-185-5p/CSF-1 signals.
Zhu W; Zhao Z; Chou F; Zuo L; Liu T; Yeh S; Bushinsky D; Zeng G; Chang C
Cell Death Dis; 2019 Mar; 10(4):275. PubMed ID: 30894518
[TBL] [Abstract][Full Text] [Related]
5. AhR activation attenuates calcium oxalate nephrocalcinosis by diminishing M1 macrophage polarization and promoting M2 macrophage polarization.
Yang X; Liu H; Ye T; Duan C; Lv P; Wu X; Liu J; Jiang K; Lu H; Yang H; Xia D; Peng E; Chen Z; Tang K; Ye Z
Theranostics; 2020; 10(26):12011-12025. PubMed ID: 33204326
[TBL] [Abstract][Full Text] [Related]
6. Calcium Oxalate Differentiates Human Monocytes Into Inflammatory M1 Macrophages.
Dominguez-Gutierrez PR; Kusmartsev S; Canales BK; Khan SR
Front Immunol; 2018; 9():1863. PubMed ID: 30186283
[TBL] [Abstract][Full Text] [Related]
7. Short Chain Fatty Acids Prevent Glyoxylate-Induced Calcium Oxalate Stones by GPR43-Dependent Immunomodulatory Mechanism.
Jin X; Jian Z; Chen X; Ma Y; Ma H; Liu Y; Gong L; Xiang L; Zhu S; Shu X; Qi S; Li H; Wang K
Front Immunol; 2021; 12():729382. PubMed ID: 34675921
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of sirtuin 1 attenuates calcium oxalate-induced kidney injury by promoting macrophage polarization.
Song BF; Li BJ; Ning JZ; Xia YQ; Ye ZH; Yuan TH; Yan XZ; Li L; Zhou XJ; Rao T; Li W; Cheng F
Int Immunopharmacol; 2023 Aug; 121():110398. PubMed ID: 37301123
[TBL] [Abstract][Full Text] [Related]
9. Sirtuin1 inhibits calcium oxalate crystal-induced kidney injury by regulating TLR4 signaling and macrophage-mediated inflammatory activation.
Duan C; Liu H; Yang X; Liu J; Deng Y; Wang T; Xing J; Hu Z; Xu H
Cell Signal; 2023 Dec; 112():110887. PubMed ID: 37717713
[TBL] [Abstract][Full Text] [Related]
10. Calcium Oxalate Stone Fragment and Crystal Phagocytosis by Human Macrophages.
Kusmartsev S; Dominguez-Gutierrez PR; Canales BK; Bird VG; Vieweg J; Khan SR
J Urol; 2016 Apr; 195(4 Pt 1):1143-51. PubMed ID: 26626217
[TBL] [Abstract][Full Text] [Related]
11. Sirtuin 3 suppresses the formation of renal calcium oxalate crystals through promoting M2 polarization of macrophages.
Xi J; Chen Y; Jing J; Zhang Y; Liang C; Hao Z; Zhang L
J Cell Physiol; 2019 Jul; 234(7):11463-11473. PubMed ID: 30588609
[TBL] [Abstract][Full Text] [Related]
12. FKBP5 deficiency attenuates calcium oxalate kidney stone formation by suppressing cell-crystal adhesion, apoptosis and macrophage M1 polarization via inhibition of NF-κB signaling.
Song Q; Song C; Chen X; Xiong Y; Li L; Liao W; Xue L; Yang S
Cell Mol Life Sci; 2023 Sep; 80(10):301. PubMed ID: 37740796
[TBL] [Abstract][Full Text] [Related]
13. Hydroxyproline stimulates inflammation and reprograms macrophage signaling in a rat kidney stone model.
Kumar P; Yang Z; Lever JM; Chávez MD; Fatima H; Crossman DK; Maynard CL; George JF; Mitchell T
Biochim Biophys Acta Mol Basis Dis; 2022 Sep; 1868(9):166442. PubMed ID: 35562038
[TBL] [Abstract][Full Text] [Related]
14. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
[TBL] [Abstract][Full Text] [Related]
15. Peeping into human renal calcium oxalate stone matrix: characterization of novel proteins involved in the intricate mechanism of urolithiasis.
Aggarwal KP; Tandon S; Naik PK; Singh SK; Tandon C
PLoS One; 2013; 8(7):e69916. PubMed ID: 23894559
[TBL] [Abstract][Full Text] [Related]
16. Pioglitazone decreased renal calcium oxalate crystal formation by suppressing M1 macrophage polarization via the PPAR-γ-miR-23 axis.
Chen Z; Yuan P; Sun X; Tang K; Liu H; Han S; Ye T; Liu X; Yang X; Zeng J; Yan L; Xing J; Xiao K; Ye Z; Xu H
Am J Physiol Renal Physiol; 2019 Jul; 317(1):F137-F151. PubMed ID: 31091119
[TBL] [Abstract][Full Text] [Related]
17. Autophagy-endoplasmic reticulum stress inhibition mechanism of superoxide dismutase in the formation of calcium oxalate kidney stones.
Kang J; Sun Y; Deng Y; Liu Q; Li D; Liu Y; Guan X; Tao Z; Wang X
Biomed Pharmacother; 2020 Jan; 121():109649. PubMed ID: 31733571
[TBL] [Abstract][Full Text] [Related]
18. Reactive oxygen species as the molecular modulators of calcium oxalate kidney stone formation: evidence from clinical and experimental investigations.
Khan SR
J Urol; 2013 Mar; 189(3):803-11. PubMed ID: 23022011
[TBL] [Abstract][Full Text] [Related]
19. Development of a two-stage model system to investigate the mineralization mechanisms involved in idiopathic stone formation: stage 2 in vivo studies of stone growth on biomimetic Randall's plaque.
O'Kell AL; Lovett AC; Canales BK; Gower LB; Khan SR
Urolithiasis; 2019 Aug; 47(4):335-346. PubMed ID: 30218116
[TBL] [Abstract][Full Text] [Related]
20. Phagocytosis model of calcium oxalate monohydrate crystals generated using human induced pluripotent stem cell-derived macrophages.
Okada T; Okada A; Aoki H; Onozato D; Kato T; Takase H; Ohshima S; Sugino T; Unno R; Taguchi K; Hamamoto S; Ando R; Shimada IS; Hashita T; Iwao T; Matsunaga T; Yasui T
Urolithiasis; 2024 Mar; 52(1):51. PubMed ID: 38554162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
